124 related articles for article (PubMed ID: 1494060)
1. [Arterial hypertension and diabetic nephropathy].
Chaignon M; Guedon J
J Mal Vasc; 1992; 17(4):311-4. PubMed ID: 1494060
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy.
Ritz E
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
[TBL] [Abstract][Full Text] [Related]
4. The renal hemodynamic basis of diabetic nephropathy.
O'Bryan GT; Hostetter TH
Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
[TBL] [Abstract][Full Text] [Related]
5. Etiology, diagnosis, and prevention of renal involvement in insulin-dependent diabetes mellitus.
Chiumello G; Beccaria L; Meschi F; Mistura L; Brambilla P; Bognetti E
Pediatrician; 1983-1985; 12(4):199-207. PubMed ID: 6400450
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
Vora JP; Leese GP; Peters JR; Owens DR
J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
[TBL] [Abstract][Full Text] [Related]
7. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
Berglund J
Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
[TBL] [Abstract][Full Text] [Related]
8. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus].
Komers R
Cas Lek Cesk; 1996 Mar; 135(5):135-9. PubMed ID: 8681353
[TBL] [Abstract][Full Text] [Related]
10. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
12. Hypertension and diabetic renal disease.
Fioretto P; Steffes MW; Mauer SM
Clin Invest Med; 1991 Dec; 14(6):630-5. PubMed ID: 1794213
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy: early detection, prevention and management.
Maher JF
Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042
[TBL] [Abstract][Full Text] [Related]
14. [Diabetic nephropathy and arterial hypertension: the physiopathological aspects and antihypertensive treatment].
Savazzi GM; Castiglioni A
Ann Ital Med Int; 1992; 7(3):160-4. PubMed ID: 1457255
[TBL] [Abstract][Full Text] [Related]
15. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
16. Diabetic hypertensive patients. Is this a group in need of particular care and attention?
Parving HH
Diabetes Care; 1999 Mar; 22 Suppl 2():B76-9. PubMed ID: 10097904
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
Elliott HL
Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
[TBL] [Abstract][Full Text] [Related]
18. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.
Parving HH
J Hypertens Suppl; 1990 Dec; 8(7):S187-91. PubMed ID: 2095388
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
[TBL] [Abstract][Full Text] [Related]
20. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]